Zhejiang Hisun Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of biological and generic drugs in China. The company provides active pharmaceutical ingredients. It also offers its products for anti-tumor, anti-infection, cardiovascular, endocrine, immunosuppression, antidepressant, and orthopedics treatment; nutrition and healthcare; and oncology, ADC small molecule, animal healthcare, and others. The company exports its products to approximately 70 countries worldwide. Zhejiang Hisun Pharmaceutical Co., Ltd. was founded in 1956 and is headquartered in Taizhou, China.
Metrics to compare | 600267 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship600267PeersSector | |
|---|---|---|---|---|
P/E Ratio | 24.5x | 20.8x | −0.5x | |
PEG Ratio | −2.28 | 0.68 | 0.00 | |
Price / Book | 1.5x | 2.6x | 2.6x | |
Price / LTM Sales | 1.3x | 2.9x | 3.2x | |
Upside (Analyst Target) | −34.2% | 26.5% | 47.6% | |
Fair Value Upside | Unlock | 3.9% | 6.1% | Unlock |